KP
BSX icon

Keel Point’s Boston Scientific BSX Stock Holding History

Keel Point’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.41M Buy
56,464
+15,000
+36% +$815K 0.14% 100
2026
Q1 		$2.6M Buy
41,464
+3,064
+8% +$245K 0.17% 83
2025
Q4 		$3.66M Buy
38,400
+32,409
+541% +$3.18M 0.22% 68
2025
Q3 		$585K Sell
5,991
-183
-3% -$19K 0.04% 267
2025
Q2 		$663K Buy
6,174
+745
+14% +$75.4K 0.04% 241
2025
Q1 		$548K Buy
5,429
+1,153
+27% +$116K 0.04% 234
2024
Q4 		$382K Buy
4,276
+457
+12% +$40.2K 0.03% 281
2024
Q3 		$320K Sell
3,819
-99
-3% -$7.8K 0.03% 317
2024
Q2 		$297K Sell
3,918
-575
-13% -$42.1K 0.03% 319
2024
Q1 		$308K Sell
4,493
-199
-4% -$12.8K 0.03% 280
2023
Q4 		$271K Buy
4,692
+405
+9% +$21.6K 0.03% 273
2023
Q3 		$226K Sell
4,287
-297
-6% -$15.6K 0.03% 281
2023
Q2 		$248K Buy
+4,584
New +$239K 0.03% 272
2023
Q1 		– Sell
-4,331
Closed -$200K – 309
2022
Q4 		$200K Buy
+4,331
New +$188K 0.03% 282

Other funds holding BSX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Keel Point's BSX Position: Q2 2026 in Review

Keel Point increased its Boston Scientific (BSX) stake by 36% in Q2 2026, buying an estimated $815K and bringing the position to 56,464 shares worth $2.41M. The position accounts for 0.14% of the portfolio, ranked #100.

Keel Point first reported a position in BSX in Q4 2022 and has held it in 14 quarters since. The position peaked at $3.66M in Q4 2025. 1,477 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Keel Point held 56,464 shares of Boston Scientific worth $2.41M as of Q2 2026.
  • Keel Point bought 15,000 Boston Scientific shares in Q2 2026, an estimated $815K.
  • Boston Scientific made up 0.14% of Keel Point's portfolio in Q2 2026, its #100 holding.
  • Keel Point first reported a position in Boston Scientific in Q4 2022 and has held it in 14 quarters since.
  • Keel Point's Boston Scientific position peaked at $3.66M in Q4 2025.
  • 1,477 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Keel Point's 13F filing for Q2 2026, filed 14 Aug 2026.